Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Oral semaglutide improves body composition and preserves lean mass in patients with type 2 diabetes: a 26-week prospective real-life study.
Front Endocrinol (Lausanne). 2023 Sep 13;14:1240263. doi: 10.3389/fendo.2023.1240263. eCollection 2023.
Front Endocrinol (Lausanne). 2023.
PMID: 37780624
Free PMC article.
Once-Weekly Subcutaneous Semaglutide Improves Fatty Liver Disease in Patients with Type 2 Diabetes: A 52-Week Prospective Real-Life Study.
Volpe S, Lisco G, Fanelli M, Racaniello D, Colaianni V, Triggiani D, Donghia R, Crudele L, Rinaldi R, Sabbà C, Triggiani V, De Pergola G, Piazzolla G.
Volpe S, et al. Among authors: racaniello d.
Nutrients. 2022 Nov 4;14(21):4673. doi: 10.3390/nu14214673.
Nutrients. 2022.
PMID: 36364937
Free PMC article.
Item in Clipboard
Once-Weekly Semaglutide Induces an Early Improvement in Body Composition in Patients with Type 2 Diabetes: A 26-Week Prospective Real-Life Study.
Volpe S, Lisco G, Racaniello D, Fanelli M, Colaianni V, Vozza A, Triggiani V, Sabbà C, Tortorella C, De Pergola G, Piazzolla G.
Volpe S, et al. Among authors: racaniello d.
Nutrients. 2022 Jun 10;14(12):2414. doi: 10.3390/nu14122414.
Nutrients. 2022.
PMID: 35745144
Free PMC article.
Item in Clipboard
Cite
Cite